APOTHEEK VISSENAKEN
0827.689.617 · rovalta.com · 26/09/2026
APOTHEEK VISSENAKEN
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOAPOTHEEK VISSENAKEN is a Private limited company incorporated in 2010. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Tienen. It employs on average 0,5 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0827.689.617
- Incorporation
- 02/07/2010
- Legal form
- Private limited company
- Registered office
- Aarschotsesteenweg 615
3300 Tienen · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 0,5 ETP
Joint committees (1)
- 313
Financials
Source · NBB, 15 filingsTrend over 15 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 89,5 k € | +2.3% | 87,6 k € | -7.9% | 95,1 k € | +24.3% | 76,5 k € | -3.9% | 79,6 k € |
| EBITDA | 79,3 k € | +46.0% | 54,3 k € | +11.0% | 49 k € | +18.9% | 41,2 k € | +0.5% | 41 k € |
| Operating result | 61,8 k € | +64.7% | 37,5 k € | +24.0% | 30,3 k € | +63.4% | 18,5 k € | +4.2% | 17,8 k € |
| Net result | 56,7 k € | +116% | 26,2 k € | +23.2% | 21,3 k € | +125% | 9,4 k € | -68.4% | 29,9 k € |
| Balance sheet | |||||||||
| Equity | 145 k € | +0.5% | 144,3 k € | +1.2% | 142,6 k € | +0.2% | 142,3 k € | +0.0% | 142,3 k € |
| Total assets | 563,7 k € | +2.8% | 548,1 k € | +0.5% | 545,2 k € | +0.1% | 544,8 k € | -7.2% | 586,9 k € |
| Cash | 42,6 k € | +2.8% | 41,4 k € | +39.9% | 29,6 k € | +32.3% | 22,4 k € | -47.3% | 42,5 k € |
| Debts | 407,9 k € | +4.6% | 389,9 k € | -1.6% | 396,1 k € | +0.1% | 395,6 k € | -11.0% | 444,3 k € |
| Other | |||||||||
| Workforce | 0,5 ETP | -28.6% | 0,7 ETP | -22.2% | 0,9 ETP | +12.5% | 0,8 ETP | +14.3% | 0,7 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 6 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 14/08/2026 | 27/08/2025 | 28/08/2024 | 31/08/2023 | 29/07/2022 | 27/08/2021 |
| General meeting | 29/05/2026 | 30/05/2025 | 31/05/2024 | 26/05/2023 | 27/05/2022 | 28/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 15 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 29/05/2026 | 14/08/2026 | Dutch | |
| Abridged model | 31/12/2024 | 30/05/2025 | 27/08/2025 | Dutch | |
| Abridged model | 31/12/2023 | 31/05/2024 | 28/08/2024 | Dutch | |
| Abridged model | 31/12/2022 | 26/05/2023 | 31/08/2023 | Dutch | |
| Abridged model | 31/12/2021 | 27/05/2022 | 29/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 28/05/2021 | 27/08/2021 | Dutch | |
| Abridged model | 31/12/2019 | 31/08/2020 | 13/11/2020 | Dutch | |
| Abridged model | 31/12/2018 | 31/05/2019 | 26/08/2019 | Dutch | |
| Abridged model | 31/12/2017 | 25/05/2018 | 18/07/2018 | Dutch | |
| Abridged model | 31/12/2016 | 26/05/2017 | 12/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 27/05/2016 | 31/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 29/05/2015 | 01/06/2015 | Dutch | |
| Abridged model | 31/12/2013 | 30/05/2014 | 17/09/2014 | Dutch | |
| Abridged model | 31/12/2012 | 31/05/2013 | 10/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 25/05/2012 | 14/08/2012 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 6 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates21/11/2022STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - DOEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Mandates24/09/2019ONTSLAGEN - BENOEMINGEN
- Mandates13/10/2017ONTSLAGEN - BENOEMINGEN
- Other20/07/2010RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202556,7 k €↑
- 2024Annual accounts 202426,2 k €↑
- 2023Annual accounts 202321,3 k €↑
- 2022Annual accounts 20229,4 k €↓
- 2022Name changeAPOTHEEK VISSENAKEN
- 2021Annual accounts 202129,9 k €↑
- 2021Name changeVANDEWYER APOTHEEK
- 2020Annual accounts 202019,1 k €↑
- 2019Annual accounts 2019-15,5 k €↓
- 2018Annual accounts 201852,1 k €↑
- 2017Annual accounts 2017-9,2 k €↓
- 2016Annual accounts 20164 k €↓
- 2015Annual accounts 201523,4 k €↓
- 2014Annual accounts 201423,6 k €↓
- 2013Annual accounts 201328,6 k €↑
- 2012Annual accounts 2012-9,8 k €↓
- 2011Annual accounts 201147,9 k €
- 02/07/2010IncorporationPrivate limited company